Role of GPX4 in ferroptosis and its pharmacological implicationTobias Seibt(LMU Klinikum), Bettina Proneth(Helmholtz Zentrum München), Marcus Conrad(Helmholtz Zentrum München)Free Radical Biology and MedicineSeptember 13, 201810.1016/j.freeradbiomed.2018.09.014Cited by 1,487SaveCiteExport RISWatch citationsAbstractRelated PapersFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathScott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al.|Cell|2012|17.9kGlutaminolysis and Transferrin Regulate FerroptosisMinghui Gao, Prashant Monian, Nosirudeen Quadri et al.|Molecular Cell|2015|2kAlterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaJeswinder Sian, David T. Dexter, Andrew J. Lees et al.|Annals of Neurology|1994|1.2kIncreased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's DiseaseDavid T. Dexter, F. R. Wells, Alyssa Lee et al.|Journal of Neurochemistry|1989|1.1kCloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct ProteinsHideyo Sato, Michiko Tamba, Tetsuro Ishii et al.|Journal of Biological Chemistry|1999|1.1k